V, R., E, L., & M, L. G. (2022). Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases. Cell death & disease, 13(3), 248. https://doi.org/10.1038/s41419-022-04688-x
Chicago Style (17th ed.) CitationV, Risso, Lafont E, and Le Gallo M. "Therapeutic Approaches Targeting CD95L/CD95 Signaling in Cancer and Autoimmune Diseases." Cell Death & Disease 13, no. 3 (2022): 248. https://doi.org/10.1038/s41419-022-04688-x.
MLA (9th ed.) CitationV, Risso, et al. "Therapeutic Approaches Targeting CD95L/CD95 Signaling in Cancer and Autoimmune Diseases." Cell Death & Disease, vol. 13, no. 3, 2022, p. 248, https://doi.org/10.1038/s41419-022-04688-x.
Warning: These citations may not always be 100% accurate.